APA (7th ed.) Citation

N, H., C, W., QQ, Z., ZJ, Z., X, D., & Y, Z. (2026). Oliceridine versus Sufentanil for Postoperative Recovery and Opioid-Related Adverse Events in Patients Undergoing Thoracoscopic Lobectomy: A Randomized Double-Blind Controlled Trial. Drug design, development and therapy, 20, 582482. https://doi.org/10.2147/DDDT.S582482

Chicago Style (17th ed.) Citation

N, Hu, Wang C, Zhang QQ, Zhang ZJ, Ding X, and Zhang Y. "Oliceridine Versus Sufentanil for Postoperative Recovery and Opioid-Related Adverse Events in Patients Undergoing Thoracoscopic Lobectomy: A Randomized Double-Blind Controlled Trial." Drug Design, Development and Therapy 20 (2026): 582482. https://doi.org/10.2147/DDDT.S582482.

MLA (9th ed.) Citation

N, Hu, et al. "Oliceridine Versus Sufentanil for Postoperative Recovery and Opioid-Related Adverse Events in Patients Undergoing Thoracoscopic Lobectomy: A Randomized Double-Blind Controlled Trial." Drug Design, Development and Therapy, vol. 20, 2026, p. 582482, https://doi.org/10.2147/DDDT.S582482.